The difficulties in diagnostic and treatment of pneumonia in kidney transplant recipients. A case description

The pneumonia after transplantation is a common complication. This complication is really dangerous and has a high mortality rate due to use of immunosuppressive drugs. This results in poor clinic and laboratory manifestations of pulmonary diseases that develops fulminantly inducing pulmonary failure and is resistant to standard therapy. The diagnostic and treatment of such patients requires special experience of medical staff. We present a case of successful treatment of pneumonia in a kidney transplant recipient.

трансплантация почки, лекарственный иммунодефицит, пневмония, кандидоз, renal transplantation, immunosuppression, pneumonia, candidosis

1. Клясова Г.А. Место Кансидаса в лечении инвазивных микозов // РМЖ. 2004. Т. 12. № 5. С. 336–340.

2. Лобзин Ю.В. с соавт. Первый в России клинический опыт успешного применения каспофунгина при инвазивном кандидозе у пациента с тяжелой печеночной недостаточностью // Клин Микробиол Антимкробн химиотер. 2005. Т. 7. № 4. С. 403–409.

3. Практическое руководство по антиинфекционной химиотерапии / Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. Смоленск: МАКМАХ, 2007. 464 с.

4. Прокопенко Е.И. Легочные инфекции у пациентов с почечным трансплантатом // Нефрология и диализ. 2008. Т. 10. № 1. С. 6–15.

5. Томилина Н.А., Бикбов Б.Т. с соавт. Нефрология в Москве: история, современное состояние, перспективы развития // Материалы 2-ой региональной конференции РДО «Нефрология и диализ в Москве». Январь 2009.

6. Хазов М.В., Романов С.В. с соавт. Трансплантация почки в ФГУ «ПОМЦ Росздрава»: опыт и перспективы развития // Мед. Альманах. 2008. Материалы II Международной конференции «Высокие технологии в медицине». С. 45–48.

7. Шумаков В.И., Томилина Н.А., Мойсюк Я.Г. с соавт. Отдаленные результаты трансплантации трупной почки на современном этапе (опыт последнего десятилетия) // Материалы конференции «Клиническая трансплантология органов». 2005. С 116–117.

8. American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation // Am J Transplant. 2006. Vol. 6 (2). P. 262–274.

9. Baughman R.P. Use of bronchoscopy in the diagnosis of infection in the immunocompromised host // Thorax. 1994. Vol. 49. P. 3–7.

10. Berenguer J. et al. Pathogenesis of pulmonary aspergillosis: granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression // Am J Respir Crit Care Med. 1995. Vol. 152. P. 1079–1086.

11. Bodey G.P., Buckley M. et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia // Ann Intern Med. 1966. Vol. 64 (2). P. 328–40.

12. Chang G.C., Chang K.M. et al. Clinical patterns among invasive pulmonary aspergillosis patients with and without recent intensive immunosuppressive therapy // J Formos Med Assoc. 2001. Vol. 100. P. 762–766.

13. Chang G.C., Wu C.L. et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures // Chest. Feb. 2004. Vol. 125 (2). P. 541–7.

14. Collin B.A., Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients // Infect Dis Clin North Am. 1998. Vol. 12. P. 781–805.

15. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis // Am J Respir Crit Care Med. 2003. Vol. 168 (8). P. 918–51.

16. Johnson P.C. et al. The rapid diagnosis of pulmonary infections in solid organ transplant recipients // Semin Respir Infect. 1990. Vol. 5. P. 2–9.

17. Kahn F.W., Jones J.M. Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory // J Clin Microbiol. 1988. Vol. 26. P. 1150–1155.

18. Maertens J. et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis // J Clin Microbiol. 1999. Vol. 37. P. 3223–3228.

19. Mandell L.A. et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults // Clin Infect Dis. 2007. Vol. 44 (Suppl 2). P. 27–72.

20. Neely M., Blumer J. Pharmacokinetic characteristics of caspofungin in two pediatric liver transplant patients // Curr. Ther. Res. Clin. Exp. 2003. Vol. 64. P. 127–136.

21. Pappas P. et al. Guidelines for treatment of candidiasis // Clin Infect Dis. 2004. Vol. 38. P. 161–189.

22. Peleg A.Y. et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study // Clin Infect Dis. 2007. Vol. 44 (10). P. 1307–14.

23. Ramanujam P., Rathlev N.K. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia // Acad Emerg Med. 2006. Vol. 13 (7). P. 740–5.

24. Ramsey P.G. et al. The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management // Medicine (Baltimore). 1980. Vol. 59. P. 206–222.

25. Rano A. et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures // Thorax. 2001. Vol. 56. P. 379–387.

26. Raеє A. et al. Pulmonary infections in non-HIV-immunocompromised patients // Curr Opin Pulm Med. 2005. Vol. 11 (3). P. 213–7.

27. Rettkowski O. et al. Prophylaxis and Treatment of Pneumocystis jirovecii Pneumonia after Renal Transplantation // Transplantationsmedizin. 2008. Vol. 20. P. 21.

28. Rubin R.H. The Changing Pattern of Infections Following Transplantation // ASN Renal Week Official Symposium. November. 2005.

29. Sanz-Rodriguez C. et al. Caspofungin Therapy in Documented Fungal Infections: Spanish Experience Before Licensure of the Drug // Chemother. 2002. Vol. 27–30. P. 42. Abstract no. M-895.

30. Sileri P., Pursell K.J. et al. A standardized protocol for the treatment of severe pneumonia in kidney transplant recipients // Clin Transplant. 2002. Vol. 16. P. 450–454.

31. Sternberg R.I. et al. Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients // Am J Med. 1993. Vol. 95. P. 358–364.

32. Stone J.A., et al. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men // Antimicrob. Agents Chemother. 2002. Vol. 46. №3. P. 739–45.

33. The 10th Annual Report of the UK Renal Registry, 2007.

34. Theoklis E. Zaoutis et al. A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients // Pediatrics. 2009. Vol. 123. No. 3. P. 877–884.

35. Thorpe J.E. et al. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia // J Infect Dis. 1987. Vol. 155. P. 855–861.

36. Torres A. et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation // Chest. 2000. Vol. 117. P. 494–502.